4BIO Capital

4BIO Capital is a London-based venture capital firm that concentrates entirely on advanced therapies. It backs early-stage companies developing treatments where patients have few or no good options, with the stated goal of widening access to potentially curative medicines.

Products and services

• Venture investment: provides funding to young companies in advanced therapies.
• Expert guidance: gives portfolio companies advice from scientists and life science investors.
• Investor access: lets investors take part in the advanced therapy field through the firm.

Who it serves

The firm looks for early-stage companies working on cell therapy, gene therapy, RNA treatments, targeted therapies and the microbiome. Its investor clients want exposure to this area of medicine.

Key facts

• Based in: London, UK
• Focus: advanced therapies only
• Team: advanced therapy scientists together with experienced life science investors
• Publications: the team says it has authored more than 250 scientific articles in journals such as Nature, The Lancet and Cell